Polarean Imaging (GB:POLX) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Polarean Imaging plc has announced a trade-in agreement with the University of Kansas Medical Center to upgrade their MRI technology with Polarean’s latest FDA-approved clinical-grade Xenon MRI system. The new system will enhance research across multiple lung diseases and is expected to be installed later this year, aiding in clinical imaging and various studies including NIH-funded and pharmaceutical-sponsored trials. This upgrade signifies the increasing significance of Xenon MRI technology in pulmonary diagnostics and treatment monitoring.
For further insights into GB:POLX stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue